Business Description
Yubo International Biotech Ltd
NAICS : 334517
SIC : 3841
ISIN : US9883661004
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.02 | |||||
Equity-to-Asset | -1.46 | |||||
Debt-to-Equity | -0.2 | |||||
Debt-to-EBITDA | -0.4 | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -8.76 | |||||
Beneish M-Score | -3.6 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -23.1 | |||||
3-Year EBITDA Growth Rate | -10.1 | |||||
3-Year EPS without NRI Growth Rate | -18.6 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 83.59 | |||||
9-Day RSI | 63.61 | |||||
14-Day RSI | 50.6 | |||||
6-1 Month Momentum % | -82.79 | |||||
12-1 Month Momentum % | -82.81 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.19 | |||||
Quick Ratio | 0.17 | |||||
Days Inventory | 767.73 | |||||
Days Sales Outstanding | 81.04 | |||||
Days Payable | 2892.11 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.5 | |||||
Shareholder Yield % | 11.82 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 80.4 | |||||
Operating Margin % | -306.17 | |||||
Net Margin % | -319.16 | |||||
FCF Margin % | -197.14 | |||||
ROA % | -82.24 | |||||
ROIC % | -75.28 | |||||
3-Year ROIIC % | -1509.37 | |||||
ROC (Joel Greenblatt) % | -176.63 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 20.49 | |||||
EV-to-EBIT | -3.64 | |||||
EV-to-EBITDA | -4.37 | |||||
EV-to-Revenue | 12.17 | |||||
EV-to-FCF | -6.57 | |||||
Earnings Yield (Greenblatt) % | -27.47 | |||||
FCF Yield % | -9.12 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:YBGJ
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Yubo International Biotech Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 0.454 | ||
EPS (TTM) ($) | -0.007 | ||
Beta | 2.43 | ||
Volatility % | 363 | ||
14-Day RSI | 50.6 | ||
14-Day ATR ($) | 0.037537 | ||
20-Day SMA ($) | 0.048562 | ||
12-1 Month Momentum % | -82.81 | ||
52-Week Range ($) | 0.031 - 1.37 | ||
Shares Outstanding (Mil) | 119.82 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Yubo International Biotech Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Yubo International Biotech Ltd Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Yubo International Biotech Ltd Frequently Asked Questions
What is Yubo International Biotech Ltd(YBGJ)'s stock price today?
When is next earnings date of Yubo International Biotech Ltd(YBGJ)?
Does Yubo International Biotech Ltd(YBGJ) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |